News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19

Publish date: December 22, 2021

 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

12 state boards have disciplined docs for COVID misinformation
MDedge Endocrinology
COVID-19 asymptomatic infection rate remains high
MDedge Endocrinology
Even COVID-19 can’t stop a true optimist
MDedge Endocrinology
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
MDedge Endocrinology
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
MDedge Endocrinology
COVID cases spike as questions remain about Omicron’s threat
MDedge Endocrinology
Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
MDedge Endocrinology
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
MDedge Endocrinology
Bamlanivimab’s effects in COVID-19 depend on antibodies
MDedge Endocrinology
Pandemic poses short- and long-term risks to babies, especially boys
MDedge Endocrinology